MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, S. E.
Right arrow Articles by Baenziger, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, S. E.
Right arrow Articles by Baenziger, J. E.

Vol. 55, Issue 2, 348-355, February 1999

A Structure-Based Approach to Nicotinic Receptor Pharmacology

Stephen E. Ryan and John E. Baenziger

Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada

Infrared difference spectroscopy has been used to examine the structural effects of local anesthetic (LA) binding to the nicotinic acetylcholine receptor (nAChR). Several LAs induce subtle changes in the vibrational spectrum of the nAChR over a range of concentrations consistent with their reported nAChR-binding affinities. At concentrations of the desensitizing LAs prilocaine and lidocaine consistent with their binding to the ion channel pore, the vibrational changes suggest the stabilization of an intermediate conformation that shares structural features in common with both the resting and desensitized states. Higher concentrations of prilocaine and lidocaine, as well as the LA dibucaine, lead to additional binding to the neurotransmitter-binding site, the formation of physical interactions (most notably cation-tyrosine interactions) between LAs and neurotransmitter-binding-site residues, and the subsequent formation of a presumed desensitized nAChR. Although concentrations of the LA tetracaine consistent with binding to the ion channel pore elicit a reversed pattern of spectral changes suggestive of a resting state-like nAChR, higher concentrations also lead to neurotransmitter site binding and desensitization. Our results suggest that LAs stabilize multiple conformations of the nAChR by binding to at least two conformationally sensitive LA-binding sites. The spectra also reveal subtle differences in the strengths of the physical interactions that occur between LAs and binding-site residues. These differences correlate with LA potency at the nAChR.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
J. E. Baenziger, S. E. Ryan, M. M. Goodreid, N. Q. Vuong, R. M. Sturgeon, and C. J. B. daCosta
Lipid Composition Alters Drug Action at the Nicotinic Acetylcholine Receptor
Mol. Pharmacol., March 1, 2008; 73(3): 880 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
C. J. B. daCosta, D. E. E. Kaiser, and J. E. Baenziger
Role of Glycosylation and Membrane Environment in Nicotinic Acetylcholine Receptor Stability
Biophys. J., March 1, 2005; 88(3): 1755 - 1764.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. B. daCosta, I. D. Wagg, M. E. McKay, and J. E. Baenziger
Phosphatidic Acid and Phosphatidylserine Have Distinct Structural and Functional Interactions with the Nicotinic Acetylcholine Receptor
J. Biol. Chem., April 9, 2004; 279(15): 14967 - 14974.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
M. Liu and A. Barth
TNP-AMP Binding to the Sarcoplasmic Reticulum Ca2+-ATPase Studied by Infrared Spectroscopy
Biophys. J., November 1, 2003; 85(5): 3262 - 3270.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. E. Ryan, D. G. Hill, and J. E. Baenziger
Dissecting the Chemistry of Nicotinic Receptor-Ligand Interactions with Infrared Difference Spectroscopy
J. Biol. Chem., March 15, 2002; 277(12): 10420 - 10426.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. B. daCosta, A. A. Ogrel, E. A. McCardy, M. P. Blanton, and J. E. Baenziger
Lipid-Protein Interactions at the Nicotinic Acetylcholine Receptor. A FUNCTIONAL COUPLING BETWEEN NICOTINIC RECEPTORS AND PHOSPHATIDIC ACID-CONTAINING LIPID BILAYERS
J. Biol. Chem., January 4, 2002; 277(1): 201 - 208.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. L. Gentry and R. J. Lukas
Local Anesthetics Noncompetitively Inhibit Function of Four Distinct Nicotinic Acetylcholine Receptor Subtypes
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1038 - 1048.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
R. L. Papke, B. A. Horenstein, and A. N. Placzek
Inhibition of Wild-Type and Mutant Neuronal Nicotinic Acetylcholine Receptors by Local Anesthetics
Mol. Pharmacol., December 1, 2001; 60(6): 1365 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. E. Baenziger, M.-L. Morris, T. E. Darsaut, and S. E. Ryan
Effect of Membrane Lipid Composition on the Conformational Equilibria of the Nicotinic Acetylcholine Receptor
J. Biol. Chem., January 14, 2000; 275(2): 777 - 784.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. E. Ryan, M. P. Blanton, and J. E. Baenziger
A Conformational Intermediate between the Resting and Desensitized States of the Nicotinic Acetylcholine Receptor
J. Biol. Chem., February 9, 2001; 276(7): 4796 - 4803.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics